Diana De Vore, PHARMD
Ambulatory Care · Santa Clara
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Diana De Vore’s office at (408) 851-1000 to ask if they take your plan before you enroll.
California Medical Board record
Licence G79190 · Current
Licensed to practise in California · since 1994 · expires 2028-03-31 · Jefferson Medical College of Thomas Jefferson University.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$226,267
Pharmacies billed $226,267 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,496) in 2024. At or below the middle of the specialty; the typical pharmacist clinician is at 0%.
989 generic and 438 brand-name prescriptions · $226,267 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 169 | $125,824 | $745 |
| Jardiance | 72 | $25,705 | $357 |
| Liraglutide | 15 | $8,892 | $593 |
| Victoza 2-Pak | 13 | $8,459 | $651 |
| Humulin N | 50 | $7,387 | $148 |
See all 27 drugs
| Ozempic | 169 | $125,824 | $745 |
| Jardiance | 72 | $25,705 | $357 |
| Liraglutide | 15 | $8,892 | $593 |
| Victoza 2-Pak | 13 | $8,459 | $651 |
| Humulin N | 50 | $7,387 | $148 |
| Humulin N Kwikpen | 24 | $5,386 | $224 |
| Insulin Glargine-Yfgn | 32 | $4,224 | $132 |
| Humulin R | 24 | $2,743 | $114 |
| Atorvastatin | 195 | $2,330 | $12 |
| Metformin | 165 | $1,894 | $11 |
| Glipizide | 97 | $1,101 | $11 |
| Glipizide Er | 32 | $869 | $27 |
| Metformin Hcl Er | 86 | $829 | $10 |
| Losartan | 68 | $820 | $12 |
| Lisinopril | 58 | $670 | $12 |
| Amlodipine Besylate | 53 | $611 | $12 |
| Ultra-Fine Mini Pen Needle | 20 | $383 | $19 |
| Veo Insulin | 15 | $379 | $25 |
| Rosuvastatin | 34 | $362 | $11 |
| Simvastatin | 31 | $362 | $12 |
| Ultra-Fine Nano Pen Needle | 14 | $355 | $25 |
| Lisinopril-Hydrochlorothiazide | 27 | $342 | $13 |
| Glimepiride | 23 | $336 | $15 |
| Hydrochlorothiazide | 16 | $200 | $13 |
| Losartan-Hydrochlorothiazide | 17 | $193 | $11 |
| Metoprolol | 12 | $167 | $14 |
| Metoprolol | 12 | $130 | $11 |
Year by year
| 2024 | 1,496 | 271 | 0% (0) | 29% | $226,267 |
| 2023 | 942 | 205 | 0% (0) | 24% | $114,066 |
| 2022 | 999 | 173 | 0% (0) | 22% | $72,865 |
| 2021 | 588 | 159 | 0% (0) | 25% | $48,471 |
| 2020 | 413 | 149 | 0% (0) | 33% | $62,052 |
| 2019 | 12 | None | 0% (0) | None | $318 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 21 drugs
| Ozempic | 34 | $28,796 | $847 |
| Victoza 2-Pak | 25 | $25,716 | $1,029 |
| Jardiance | 32 | $13,660 | $427 |
| Humulin N | 41 | $7,051 | $172 |
| Humulin N Kwikpen | 19 | $5,246 | $276 |
| Humulin R | 22 | $2,887 | $131 |
| Insulin Glargine-Yfgn | 13 | $2,212 | $170 |
| Atorvastatin | 124 | $1,769 | $14 |
| Metformin | 108 | $1,301 | $12 |
| Glipizide Er | 41 | $1,064 | $26 |
| Glipizide | 59 | $767 | $13 |
| Metformin Hcl Er | 68 | $656 | $10 |
| Losartan | 44 | $548 | $12 |
| Lisinopril | 41 | $524 | $13 |
| Amlodipine Besylate | 34 | $407 | $12 |
| Ultra-Fine Mini Pen Needle | 15 | $375 | $25 |
| Ultra-Fine Nano Pen Needle | 18 | $367 | $20 |
| Veo Insulin | 16 | $342 | $21 |
| Rosuvastatin | 21 | $269 | $13 |
| Simvastatin | 21 | $242 | $12 |
| Glimepiride | 14 | $223 | $16 |
2022: 23 drugs
| Victoza 2-Pak | 16 | $13,329 | $833 |
| Jardiance | 26 | $12,239 | $471 |
| Humulin N | 53 | $9,988 | $188 |
| Humulin N Kwikpen | 45 | $9,444 | $210 |
| Humulin R | 29 | $4,082 | $141 |
| Lantus | 16 | $3,876 | $242 |
| Atorvastatin | 130 | $1,658 | $13 |
| Metformin | 125 | $1,466 | $12 |
| Glipizide | 100 | $1,244 | $12 |
| Losartan | 55 | $667 | $12 |
| Ultra-Fine Mini Pen Needle | 22 | $654 | $30 |
| Veo Insulin | 26 | $612 | $24 |
| Lisinopril | 47 | $549 | $12 |
| Metformin Hcl Er | 60 | $534 | $9 |
| Glipizide Er | 15 | $480 | $32 |
| Amlodipine Besylate | 35 | $418 | $12 |
| Pioglitazone | 19 | $393 | $21 |
| Simvastatin | 23 | $268 | $12 |
| Hydrochlorothiazide | 21 | $253 | $12 |
| Ultra-Fine Nano Pen Needle | 11 | $250 | $23 |
| Glimepiride | 15 | $248 | $17 |
| Veo Insulin | 11 | $245 | $22 |
| Lisinopril-Hydrochlorothiazide | 12 | $136 | $11 |
2021: 16 drugs
| Humulin N | 61 | $10,648 | $175 |
| Lantus | 12 | $4,566 | $381 |
| Humulin 70-30 | 17 | $4,010 | $236 |
| Humulin R | 23 | $2,759 | $120 |
| Humulin N Kwikpen | 14 | $2,201 | $157 |
| Glipizide | 92 | $1,228 | $13 |
| Atorvastatin | 75 | $945 | $13 |
| Veo Insulin | 24 | $580 | $24 |
| Metformin | 34 | $418 | $12 |
| Lisinopril | 34 | $383 | $11 |
| Metformin Hcl Er | 37 | $342 | $9 |
| Veo Insulin | 14 | $297 | $21 |
| Simvastatin | 25 | $292 | $12 |
| Amlodipine Besylate | 18 | $230 | $13 |
| Glimepiride | 11 | $168 | $15 |
| Losartan | 12 | $153 | $13 |
2020: 11 drugs
| Humulin N | 62 | $12,635 | $204 |
| Lantus | 12 | $9,920 | $827 |
| Humulin 70-30 | 19 | $5,959 | $314 |
| Humulin R | 15 | $2,597 | $173 |
| Glipizide | 65 | $862 | $13 |
| Atorvastatin | 44 | $679 | $15 |
| Veo Insulin | 36 | $580 | $16 |
| Metformin | 23 | $272 | $12 |
| Veo Insulin | 15 | $233 | $16 |
| Lisinopril | 17 | $198 | $12 |
| Metformin Hcl Er | 19 | $189 | $10 |
Professional record
- NPI
- 1699298976
- Licence
- CA 79190California G79190: Current · expires 2028-03-31
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 1835P2201X (1835P2201X); Student in a training program (390200000X)
- Mailing address
- 2514 Jefferson Ave, Redwood City, CA, 94062
- NPI first listed
- 2017-07-19
- NPI last updated
- 2019-09-04
This is when the NPI record was last certified, not a medical board exam.